Children's Cancer Group, China
11 clinical trials · Sponsor
◉ Watch Children's Cancer Group, China
| Record | Firm | Date |
|---|---|---|
| Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents (NCT07168980) | Children's Cancer Group, China | 2025-07-01 |
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment (NCT06563245) | Children's Cancer Group, China | 2024-09-25 |
| Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL) (NCT05681260) | Children's Cancer Group, China | 2023-02-06 |
| CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL (NCT04881838) | Children's Cancer Group, China | 2021-03-01 |
| CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma (NCT04726501) | Children's Cancer Group, China | 2018-04-01 |
Track Children's Cancer Group, China automatically
Every clearance here is in the API, with alerts when new ones post.